Julien Le Noble
Julien Le Noble headed CME Group's Singapore-based Asia Pacific office from Aug. 1, 2011 to September 2014, when he resigned after a major reshuffle of top management at CME.  He was a member of the senior leadership team of CME Group representing Asia Pacific and was responsible for leading CME Group's efforts to develop products and services in the region. 
He was also a director on the board of Bursa Malaysia Derivatives, representing CME Group’s interests as a 25% shareholder.
Le Noble was previously chief executive and representative director, Japan and Head of Equities, Asia Pacific for Newedge, where he oversaw the integration of the Fimat and Calyon businesses, which formed Newedge. His 16-year career at Fimat included a five-year stint in Chicago.